Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?

S M Marshall1

  • 1Faculty of Clinical Medical Sciences, Institute of Cellular Medicine, Newcastle University, Floor 4, Leech Building, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. sally.marshall@newcastle.ac.uk

Diabetologia
|June 15, 2012
PubMed

Insights

Diabetic nephropathy significantly impacted type 1 diabetes patients in the 1980s, with many developing kidney failure. While treatments have improved outcomes, further research is needed to prevent chronic kidney disease progression.

Area of Science:

  • Nephrology
  • Endocrinology
  • Epidemiology

Background:

  • Diabetic nephropathy was a severe complication in type 1 diabetes during the 1980s.
  • Epidemiological studies highlighted high rates of persistent proteinuria and mortality within 7-8 years of onset.
  • Microalbuminuria was identified as an early marker for disease progression.

Purpose of the Study:

  • To review historical data on diabetic nephropathy from the 1980s.
  • To assess the impact of early identification and treatment on disease progression.
  • To discuss current challenges and future directions in managing diabetic kidney disease.

Main Methods:

  • Review of seminal papers on diabetic nephropathy published in Diabetologia in the 1980s.
  • Analysis of epidemiological data on proteinuria and mortality in type 1 diabetes.
  • Examination of studies identifying microalbuminuria and its predictive value.

Main Results:

  • 41% of type 1 diabetes patients developed persistent proteinuria after 40 years.
  • Median survival after proteinuria onset was 7-8 years, often due to uremia or cardiovascular disease.
  • Microalbuminuria predicted progression to proteinuria, prompting hopes for earlier intervention.

Conclusions:

  • Early detection of microalbuminuria offered hope for preventing end-stage kidney disease.
  • While outcomes have improved, current strategies may delay rather than prevent kidney failure.
  • Further research is crucial to understand cohort variations and develop novel therapies for chronic kidney disease.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...